Anna Maria Rachiglio

Author

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"ORCID

Also Known As

A Rachiglio, A. Rachiglio, A.M. Rachiglio, Anna M. Rachiglio, Anna Maria Rachiglio, Anna Rachiglio, AnnaMaria Rachiglio, Annamaria Rachiglio, M. Rachiglio, Rachiglio

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"Casa Sollievo della Sofferenza University of Campania "Luigi Vanvitelli"University of Naples Federico II Istituti di Ricovero e Cura a Carattere Scientifico

About

Anna Maria Rachiglio is an author at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" specializing in medicine, radiation oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	539
2	Cell Biology	3	3	79
3	Engineering	1	1	112
4	Health Sciences	1	1	24
5	Immunology	1	1	53

Anna Maria Rachiglio

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial Nicola Normanno, Anna Maria Rachiglio, Matilde Lambiase, Annals of Oncology Capri Goim TrialMedicinePathologyColorectal CancerMetastatic Colorectal Cancer	2015	145
RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial Nicola Normanno, Riziero Esposito Abate, Matilde Lambiase, Annals of Oncology	2017	117
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial Fortunato Ciardiello, Nicola Normanno, Evaristo Maiello, Annals of Oncology Translational MedicineOncologyGene Mutation StatusSomatic VariantGenetic Disorder	2014	116
Molecular Typing of Lung Adenocarcinoma on Cytological Samples Using a Multigene Next Generation Sequencing Panel Aldo Scarpa, Katarzyna Sikora, Matteo Fassan, PLoS ONE EngineeringLung AdenocarcinomaPathologyMolecular TypingCytological Samples	2013	112
Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma Anna Maria Rachiglio, Riziero Esposito Abate, Alessandra Sacco, Oncotarget	2016	85
The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients Anna Maria Rachiglio, Francesca Fenizia, Maria Carmela Piccirillo, Cancers	2019	85
EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer Giulia Martini, Claudia Cardone, Pietro Paolo Vitiello, Molecular Cancer Therapeutics	2019	84
Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities Nicola Normanno, Anna Maria Rachiglio, Cristin Roma, Journal of Cellular Biochemistry	2012	69
The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies Claudia Esposito, Anna Maria Rachiglio, Maria Libera La Porta, Cancer Biology & Therapy Intrinsic ResistanceS492r MutationOncologyEgfr Monoclonal AntibodiesMedicine	2013	53
Study of Ras Mutations’ Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis Alessandro Ottaiano, Nicola Normanno, Sergio Facchini, Cancers	2020	52

Page 1